Teachers Advisors’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$723K Hold
3,928
﹤0.01% 2416
2018
Q4
$701K Hold
3,928
﹤0.01% 2358
2018
Q3
$1.26M Buy
3,928
+1,691
+76% +$600K ﹤0.01% 2202
2018
Q2
$895K Buy
2,237
+179
+9% +$78.2K ﹤0.01% 2384
2018
Q1
$738K Hold
2,058
﹤0.01% 2363
2017
Q4
$816K Buy
2,058
+284
+16% +$117K ﹤0.01% 2341
2017
Q3
$756K Hold
1,774
﹤0.01% 2385
2017
Q2
$284K Buy
+1,774
New +$242K ﹤0.01% 2891
2016
Q2
Sell
-791
Closed -$51K 3120
2016
Q1
$51K Hold
791
﹤0.01% 3005
2015
Q4
$66K Buy
791
+226
+40% +$22.7K ﹤0.01% 3053
2015
Q3
$57K Sell
565
-173
-23% -$23K ﹤0.01% 3057
2015
Q2
$93K Buy
+738
New +$111K ﹤0.01% 3054

Other funds holding ABEO

Teachers Advisors's ABEO Position: Q1 2019 in Review

Teachers Advisors held its Abeona Therapeutics (ABEO) position steady in Q1 2019 at 3,928 shares worth $723K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.

Teachers Advisors first reported a position in ABEO in Q2 2015 and has held it in 12 quarters since. The position peaked at $1.26M in Q3 2018. 87 funds tracked by Wall St. Rank hold ABEO as of Q1 2019.

  • Teachers Advisors held 3,928 shares of Abeona Therapeutics worth $723K as of Q1 2019.
  • Teachers Advisors left its Abeona Therapeutics share count unchanged in Q1 2019.
  • Abeona Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2416 holding.
  • Teachers Advisors first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 12 quarters since.
  • Teachers Advisors's Abeona Therapeutics position peaked at $1.26M in Q3 2018.
  • 87 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.